Really like this chart & can see a good rise after MM's pull price down to support at 74.4p - also 200ma weekly at 72p
Best to scale in near the support level but watch out if RSI support level is not respected or 200ma as well, be ready to move out if so.
Prudent Drug Discovery Company
Low market cap (appox £13m at time of writing).
Issues shares very rarely (last placing nearly four years ago).
Has material interest in its work from larger partners (Pharmaxis).
Sold interest in LOXL2 programme for £5m to Pharmaxis in December.
Pharmaxis continues to fund and develop LOXL2 inhibitors and Synairgen retains interest...